Notice of Intent to Sole Source – QIAGEN
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Mar 18, 2026 |
| Due Date: | Mar 25, 2026 |
| Solicitation No: | 26-000312 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Mar 18, 2026 10:34 am EDT
- Original Response Date: Mar 25, 2026 11:00 am EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Apr 09, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
-
NAICS Code:
- 339112 - Surgical and Medical Instrument Manufacturing
-
Place of Performance:
20892
This acquisition is for reagents and supplies from QIAGEN for the continued provision of clinical testing at the National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM).
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-000312
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to QIAGEN, LLC, located at 19300 Germantown Rd, Germantown, MD 20874, on a firm fixed price sole source award basis to provide annual preventative maintenance services to the National Institutes of Health.
The proposed vendor, QIAGEN, is the sole manufacturer and authorized service provider for the instrumentation. As sole developer and manufacturer of this instrument, QIAGEN is the only vendor from which purchase of reagents and supplies can be made.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by March 25, 2026 at 11am EST.
- 6707 DEMOCRACY BLVD, SUITE 106
- BETHESDA , MD 20892
- USA
- Kristin Nagashima
- kristin.nagashima@nih.gov
- Mar 18, 2026 10:34 am EDTSpecial Notice (Original)
See Also
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow 6505--Prednisolone 1% Ophthalmic Solution Active Contract Opportunity Notice ID 36E79726R0037 Related Notice
VETERANS AFFAIRS, DEPARTMENT OF
Due by 10/14/2026
Follow 65--RFI for Respirators for USWFS Active Contract Opportunity Notice ID DOIDFBO260092 Related
INTERIOR, DEPARTMENT OF THE
Due by 10/23/2026
Follow 65--LARYNGOSCOPE SET Active Contract Opportunity Notice ID SPE2DS27T0166 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Due by 10/07/2026